HomeInsightsStock Comparison

Dr Lalchandani Labs Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison

Dr Lalchandani Labs Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison

Last Updated on: Jun 22, 2025

Key Highlights

  • The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 17.93 as of 20 Jun 15:30.
  • The P/E Ratio of Dr Lalchandani Labs Ltd changed from 7.4 on March 2020 to 11 on March 2024 . This represents a CAGR of 8.25% over 5 yearsThe P/E Ratio of Global Longlife Hospital and Research Ltd changed from 25.7 on March 2023 to 0 on March 2024 . This represents a CAGR of -100.00% over 2 years.
  • The Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 3.51 crore on March 2020 to ₹ 6.81 crore on March 2024 . This represents a CAGR of 14.17% over 5 yearsThe Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 47.02 crore on March 2023 to ₹ 41 crore on March 2024 . This represents a CAGR of -6.62% over 2 years.
  • The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Historical Revenue of Dr Lalchandani Labs Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Lalchandani Labs Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Lalchandani Labs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dr Lalchandani Labs Ltd

  • Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
  • Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
  • The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Global Longlife Hospital and Research Ltd

  • Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
  • Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
  • The Promoter with the help of the Doctor team had completed the Hospital within a period of three years and started hospital in 2015-16.
  • Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

Dr Lalchandani Labs Ltd News Hub

News

Dr Lalchandani Labs to declare Quarterly Result

Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 1 May ...

Read more

25 Apr 2025 14:10

News

Dr Lalchandani Labs to announce Quarterly Result

Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 14 Oct...

Read more

09 Oct 2024 10:16

News

Dr Lalchandani Labs to conduct AGM

Dr Lalchandani Labs announced that the Annual General Meeting (AGM) of the company will be...

Read more

19 Sep 2024 17:56

News

Dr Lalchandani Labs to convene AGM

Dr Lalchandani Labs announced that the Annual General Meeting (AGM) of the company will be...

Read more

19 Sep 2024 10:10

News

Dr Lalchandani Labs schedules board meeting

Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 30 May...

Read more

21 May 2024 16:59

News

Dr Lalchandani Labs to conduct board meeting

Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 14 Nov...

Read more

08 Nov 2023 19:53

Global Longlife Hospital and Research Ltd News Hub

News

Global Longlife Hospital & Research announces board meeting date

Global Longlife Hospital & Research will hold a meeting of the Board of Directors of the C...

Read more

22 Apr 2025 10:09

News

Global Longlife Hospital & Research to declare Quarterly Result

Global Longlife Hospital & Research will hold a meeting of the Board of Directors of the C...

Read more

23 Oct 2024 10:31

News

Global Longlife Hospital & Research to hold AGM

Global Longlife Hospital & Research announced that the Annual General Meeting (AGM) of the...

Read more

06 Sep 2024 17:34

News

Global Longlife Hospital & Research to conduct AGM

Global Longlife Hospital & Research announced that the Annual General Meeting (AGM) of the...

Read more

06 Sep 2024 16:35

News

Global Longlife Hospital & Research to announce Quarterly Result

Global Longlife Hospital & Research will hold a meeting of the Board of Directors of the C...

Read more

13 May 2024 11:13

News

Global Longlife Hospital & Research to conduct EGM

Global Longlife Hospital & Research announced that an Extra Ordinary General Meeting (EGM)...

Read more

20 Apr 2024 13:51

SWOT Analysis Of Global Longlife Hospital and Research Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Dr Lalchandani Labs Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Global Longlife Hospital and Research Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Lalchandani Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dr Lalchandani Labs Ltd and Global Longlife Hospital and Research Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Global Longlife Hospital and Research Ltd?

Market cap of Dr Lalchandani Labs Ltd is 7 Cr while Market cap of Global Longlife Hospital and Research Ltd is 27 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Global Longlife Hospital and Research Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Global Longlife Hospital and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Global Longlife Hospital and Research Ltd?

As of June 22, 2025, the Dr Lalchandani Labs Ltd stock price is INR ₹17.93. On the other hand, Global Longlife Hospital and Research Ltd stock price is INR ₹26.15.

How do dividend payouts of Dr Lalchandani Labs Ltd and Global Longlife Hospital and Research Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Global Longlife Hospital and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions